Application
SYCP2 Antibody (C-term) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the SYCP2 antibody detected the SYCP2 protein (arrow).| Product Name | SYCP2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SYCP2; SCP2; Synaptonemal complex protein 2; Synaptonemal complex lateral element protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | SCP2 |
|---|---|
| Alternative Names | SYCP2 SCP2 Synaptonemal complex protein 2 Synaptonemal complex lateral element protein |
| Molecular Weight(MW) | 175639 Da |
| Function | Major component of the axial/lateral elements of synaptonemal complexes (SCS) during meiotic prophase. May be involved in the organization of chromatin by temporarily binding to DNA scaffold attachment regions. Requires SYCP3, but not SYCP1, in order to be incorporated into the axial/lateral elements (By similarity) |
| Tissue Specificity | This SYCP2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1344-1372 amino acids from the C-terminal region of human SYCP2. |
| Cellular Localization | Nucleus (By similarity). Chromosome (By similarity). Note=In axial/lateral elements of the tripartite segments of synaptonemal complexes (By similarity) |
| Entrez Gene | 10388 |
|---|---|
| Nucleotide Accession | NP_055073.2 |
Application
SYCP2 Antibody (C-term) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the SYCP2 antibody detected the SYCP2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
